Hypoglycaemia (sulfonylurea-induced)
Prolonged risk · Metabolic
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Sulfonylureas cause prolonged, recurrent low glucose. After correcting the glucose, octreotide and admission prevent rebound.
Assessment
Investigations
- Capillary and lab glucose
- Drug history
- Renal function
Management
- Correct the glucose (oral/IV)
- Octreotide for sulfonylurea cases
- Admit and monitor (prolonged risk)
- Avoid simply discharging after one correction
- Review medication
Drugs & doses
Glucose
Octreotide
Disposition
Admit and observe.
A single glucose correction is not enough — sulfonylurea lows recur.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.